Castle Biosciences Inc (NASDAQ:CSTL)
| 16.03 Delayed Data As of 3:59pm ET |  -0.49 / -2.97%Today’s Change | 9.26 Today|||52-Week Range 30.08 | -31.90% Year-to-Date |
Latest CSTL News | Press Releases
No recent news for Castle Biosciences Inc.
Today’s Trading
| Previous close | 16.52 |
| Today’s open | 16.32 |
| Day’s range | 15.99 - 16.85 |
| Volume | 6,907 |
| Average volume (3 months) | 668,708 |
| Market cap | $442.9M |
Data as of 3:59pm ET, 09/26/2023
Growth & Valuation
| Earnings growth (last year) | -107.00% |
| Earnings growth (this year) | -53.52% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | +45.65% |
| P/E ratio | NM |
| Price/Sales | 4.48 |
| Price/Book | 1.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SMTISanara Medtech Inc | -0.10 | -0.30% |
| --SanBio Co Ltd | 0.00 | 0.00% |
| --Niox Group PLC | 0.00 | 0.00% |
| NVTAInvitae Corp | -0.04 | -5.58% |
Data as of 3:59pm ET, 09/26/2023
Financials
| Next reporting date | November 13, 2023 |
| EPS forecast (this quarter) | -$0.97 |
| Annual revenue (last year) | $137.0M |
| Annual profit (last year) | -$67.1M |
| Net profit margin | -48.99% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Friendswood, Texas |
Forecasts
